Date published: 2026-4-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

MDMA Antibody (3G8): sc-57908

2.0(1)
Write a reviewAsk a question

Datasheets
  • MDMA Antibody (3G8) is a mouse monoclonal IgG1 κ MDMA antibody provided at 100 µg/ml
  • raised against MDMA conjugated to bovine thyroglobulin
  • recommended for detection of MDMA by ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for MDMA Antibody (3G8). This work is in progress.
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    MDMA Antibody (3G8) is a mouse monoclonal IgG1 kappa light chain antibody that detects MDMA protein of non-species reactive by enzyme-linked immunosorbent assay (ELISA). Anti-MDMA antibody (3G8) is available as the non-conjugated isotype antibody. MDMA, or 3,4-methylenedioxy-N-methylamphetamine, is widely recognized by its street name ecstasy and is a semisynthetic entactogen belonging to the phenethylamine family. This compound plays a significant role in modulating neurotransmitter systems in the brain, particularly by stimulating the release of serotonin while inhibiting the reuptake of serotonin, dopamine, and norepinephrine. MDMA′s function lies in inducing feelings of empathy, energy, and euphoria, which can be beneficial in therapeutic contexts, especially in treating conditions like PTSD. MDMA reaches peak blood concentrations within 1.5 to 3 hours post-ingestion and metabolizes gradually, with levels halving approximately every 8 hours. MDMA has been shown to promote the release of various hormones, including prolactin and vasopressin, which can have additional physiological effects. With a molecular weight of 193.25 g/mol, MDMA is a chiral compound typically administered as a racemate, making MDMA a subject of interest in both clinical and research settings.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    MDMA Antibody (3G8) References:

    1. The pharmacology and toxicology of 'ecstasy' (MDMA) and related drugs.  |  Kalant, H. 2001. CMAJ. 165: 917-28. PMID: 11599334
    2. Imaging brain activity in conscious monkeys following oral MDMA ('ecstasy').  |  Brevard, ME., et al. 2006. Magn Reson Imaging. 24: 707-14. PMID: 16824965
    3. Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005.  |  Teng, SF., et al. 2006. Forensic Sci Int. 161: 202-8. PMID: 16842946
    4. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.  |  Risbrough, VB., et al. 2006. Neuropsychopharmacology. 31: 2349-58. PMID: 16855533
    5. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.  |  Pirnay, SO., et al. 2006. Clin Chem. 52: 1728-34. PMID: 16858076
    6. Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.  |  Ball, KT., et al. 2006. Eur J Neurosci. 24: 217-28. PMID: 16882018
    7. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.  |  Clemens, KJ., et al. 2007. Drug Alcohol Depend. 86: 183-90. PMID: 16884865
    8. Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors.  |  Chipana, C., et al. 2006. Neuropharmacology. 51: 885-95. PMID: 16901518

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    MDMA Antibody (3G8)

    sc-57908
    100 µg/ml
    $322.00